Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
1.520
-0.050 (-3.18%)
At close: Sep 17, 2025, 4:00 PM EDT
1.500
-0.020 (-1.32%)
After-hours: Sep 17, 2025, 7:58 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $207.97 million as of September 17, 2025. Its market cap has increased by 253.51% in one year.
Market Cap
207.97M
Enterprise Value
7.41M
1-Year Change
253.51%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $207.97M, a decrease of -83.99%. That is a compound annual growth rate of -32.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 198.89M | 43.87% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | 1.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |